Market Research

Acute External Ventricular Drain Market by Patient Type (Adult, Pediatric), Application (Intracerebral Hemorrhage, Non-Traumatic Hydrocephalus Conditions, Subarachnoid Hemorrhage) - Global Forecast 2024-2030

Best Price Guarantee Length Publisher Published Date SKU
from $4,749 182 Pages 360iResearch January, 2024 IRE18417895
Best Price Guarantee
Price from $4,749
Length 182 Pages
Publisher 360iResearch
Published Date January, 2024
SKU IRE18417895

Acute External Ventricular Drain Market by Patient Type (Adult, Pediatric), Application (Intracerebral Hemorrhage, Non-Traumatic Hydrocephalus Conditions, Subarachnoid Hemorrhage) - Global Forecast 2024-2030


The Acute External Ventricular Drain Market size was estimated at USD 243.46 million in 2023 and expected to reach USD 266.64 million in 2024, at a CAGR 9.95% to reach USD 473.19 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Acute External Ventricular Drain Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Acute External Ventricular Drain Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Acute External Ventricular Drain Market, highlighting leading vendors and their innovative profiles. These include B. Braun Medical Inc., Bicakcilar Medical Devices Industry and Trade Inc., Brain Navi Biotechnology Co., Ltd., Cadila Pharmaceuticals Limited, Cook Group Incorporated, Dispomedica GmbH, Fuji Systems Co. Ltd., G. Surgiwear Ltd., Geistlich Pharma Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic Plc, Merit Medical Systems, Möller Medical Gmbh, Natus Medical Incorporated, Neuromedex GmbH, Nipro Corporation, Pfizer Inc., Raumedic AG, Salvavidas Pharmaceutical Pvt. Ltd, Silmag S.A., Sophysa SA, Spiegelberg Gmbh & Co. Kg, Wellong Instruments Co., Ltd., and Yushin Medical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Acute External Ventricular Drain Market to forecast the revenues and analyze trends in each of the following sub-markets:

Patient Type

Adult
  • Pediatric
  • Application

    Intracerebral Hemorrhage
  • Non-Traumatic Hydrocephalus Conditions
  • Subarachnoid Hemorrhage
  • Traumatic Brain Injury
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Acute External Ventricular Drain Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Acute External Ventricular Drain Market?
    3. What are the technology trends and regulatory frameworks in the Acute External Ventricular Drain Market?
    4. What is the market share of the leading vendors in the Acute External Ventricular Drain Market?
    5. Which modes and strategic moves are suitable for entering the Acute External Ventricular Drain Market?


    Note: PDF & Excel + Online Access - 1 Year


    • 1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Acute External Ventricular Drain Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Prevalence of non-traumatic hydrocephalus globally
    5.1.1.2. Need for monitoring and regulating the neurologic status of patients
    5.1.1.3. Inclination of patients toward minimally invasive medical procedures
    5.1.2. Restraints
    5.1.2.1. Uncertain time and duration of treatment
    5.1.3. Opportunities
    5.1.3.1. Rising use of real-time ultrasound navigation for EVD implantation
    5.1.3.2. Increasing medical tourism activities worldwide
    5.1.4. Challenges
    5.1.4.1. Risks associated with acute external ventricular drain
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Acute External Ventricular Drain Market, by Patient Type
    6.1. Introduction
    6.2. Adult
    6.3. Pediatric
    7. Acute External Ventricular Drain Market, by Application
    7.1. Introduction
    7.2. Intracerebral Hemorrhage
    7.3. Non-Traumatic Hydrocephalus Conditions
    7.4. Subarachnoid Hemorrhage
    7.5. Traumatic Brain Injury
    8. Americas Acute External Ventricular Drain Market
    8.1. Introduction
    8.2. Argentina
    8.3. Brazil
    8.4. Canada
    8.5. Mexico
    8.6. United States
    9. Asia-Pacific Acute External Ventricular Drain Market
    9.1. Introduction
    9.2. Australia
    9.3. China
    9.4. India
    9.5. Indonesia
    9.6. Japan
    9.7. Malaysia
    9.8. Philippines
    9.9. Singapore
    9.10. South Korea
    9.11. Taiwan
    9.12. Thailand
    9.13. Vietnam
    10. Europe, Middle East & Africa Acute External Ventricular Drain Market
    10.1. Introduction
    10.2. Denmark
    10.3. Egypt
    10.4. Finland
    10.5. France
    10.6. Germany
    10.7. Israel
    10.8. Italy
    10.9. Netherlands
    10.10. Nigeria
    10.11. Norway
    10.12. Poland
    10.13. Qatar
    10.14. Russia
    10.15. Saudi Arabia
    10.16. South Africa
    10.17. Spain
    10.18. Sweden
    10.19. Switzerland
    10.20. Turkey
    10.21. United Arab Emirates
    10.22. United Kingdom
    11. Competitive Landscape
    11.1. FPNV Positioning Matrix
    11.2. Market Share Analysis, By Key Player
    11.3. Competitive Scenario Analysis, By Key Player
    12. Competitive Portfolio
    12.1. Key Company Profiles
    12.1.1. B. Braun Medical Inc.
    12.1.2. Bicakcilar Medical Devices Industry and Trade Inc.
    12.1.3. Brain Navi Biotechnology Co., Ltd.
    12.1.4. Cadila Pharmaceuticals Limited
    12.1.5. Cook Group Incorporated
    12.1.6. Dispomedica GmbH
    12.1.7. Fuji Systems Co. Ltd.
    12.1.8. G. Surgiwear Ltd.
    12.1.9. Geistlich Pharma Inc.
    12.1.10. Integra LifeSciences Corporation
    12.1.11. Johnson & Johnson Services, Inc.
    12.1.12. Medtronic Plc
    12.1.13. Merit Medical Systems
    12.1.14. Möller Medical Gmbh
    12.1.15. Natus Medical Incorporated
    12.1.16. Neuromedex GmbH
    12.1.17. Nipro Corporation
    12.1.18. Pfizer Inc.
    12.1.19. Raumedic AG
    12.1.20. Salvavidas Pharmaceutical Pvt. Ltd
    12.1.21. Silmag S.A.
    12.1.22. Sophysa SA
    12.1.23. Spiegelberg Gmbh & Co. Kg
    12.1.24. Wellong Instruments Co., Ltd.
    12.1.25. Yushin Medical Co., Ltd.
    12.2. Key Product Portfolio
    13. Appendix
    13.1. Discussion Guide
    13.2. License & Pricing
    FIGURE 1. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET RESEARCH PROCESS
    FIGURE 2. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2023 VS 2030
    FIGURE 3. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET DYNAMICS
    FIGURE 7. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
    FIGURE 8. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
    FIGURE 10. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 12. AMERICAS ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 14. UNITED STATES ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 16. ASIA-PACIFIC ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 20. ACUTE EXTERNAL VENTRICULAR DRAIN MARKET SHARE, BY KEY PLAYER, 2023

    $4,749
    $5,749
    $6,749
    $8,749

    Research Assistance

    US: 800.298.5699
    Int'l: +1.240.747.3093
    Live help
    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Other tasks

    Cookie Settings